Published in BMJ on June 20, 1998
External review and validation of the Swedish national inpatient register. BMC Public Health (2011) 11.28
Changing perceptions in osteoporosis. BMJ (1999) 3.30
Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ (2009) 2.90
Length of hospital stay after hip fracture and short term risk of death after discharge: a total cohort study in Sweden. BMJ (2015) 1.68
Bone densitometry is not a good predictor of hip fracture. BMJ (2001) 1.67
Risk of Injurious Fall and Hip Fracture up to 26 y before the Diagnosis of Parkinson Disease: Nested Case-Control Studies in a Nationwide Cohort. PLoS Med (2016) 1.42
Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int (2007) 1.38
Epidemiology of distal forearm fractures in Oslo, Norway. Osteoporos Int (2008) 1.32
Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int (2006) 1.26
Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci U S A (1999) 1.26
Hip fracture incidence is decreasing in the high incidence area of Oslo, Norway. Osteoporos Int (2012) 1.18
Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women. Osteoporos Int (2004) 1.03
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study. Osteoporos Int (2004) 0.99
A case-control study on the effect of hormone replacement therapy on ischaemic heart disease. Br J Gen Pract (2003) 0.93
Persistent mucosal damage and risk of fracture in celiac disease. J Clin Endocrinol Metab (2014) 0.88
Genistein promotion of osteogenic differentiation through BMP2/SMAD5/RUNX2 signaling. Int J Biol Sci (2013) 0.88
Classic yin and yang tonic formula for osteopenia: study protocol for a randomized controlled trial. Trials (2011) 0.81
Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study. Br J Clin Pharmacol (2007) 0.80
Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals. BMJ (1998) 0.79
Risk of low-energy hip, wrist, and upper arm fractures among current and previous users of hormone replacement therapy: The Danish Nurse Cohort Study. Eur J Epidemiol (2004) 0.78
Risk factors for hip fracture and a possible effect modification by hormone replacement therapy. The Danish nurse cohort study. Eur J Epidemiol (2005) 0.76
Preparative Purification of Bioactive Compounds from Flos Chrysanthemi Indici and Evaluation of Its Antiosteoporosis Effect. Evid Based Complement Alternat Med (2016) 0.75
Clec11a/osteolectin is an osteogenic growth factor that promotes the maintenance of the adult skeleton. Elife (2016) 0.75
Extraintestinal Complications of Inflammatory Bowel Disease. Curr Treat Options Gastroenterol (2001) 0.75
Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89
Involutional osteoporosis. N Engl J Med (1986) 8.20
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1995) 2.58
The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol (1984) 1.80
Progesterone as a bone-trophic hormone. Endocr Rev (1990) 1.43
Epidemiology of osteoporosis. Bone (1992) 1.38
Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab (1987) 1.36
The effect of estrogen dose on postmenopausal bone loss. N Engl J Med (1983) 1.27
Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med (1991) 1.24
Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study. JAMA (1997) 1.21
Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Ann Intern Med (1990) 1.12
Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet (1985) 1.05
Calcium in the prevention and treatment of osteoporosis. J Intern Med (1992) 1.04
Estrogens, bone loss and preservation. Osteoporos Int (1990) 1.01
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ (1992) 1.00
Better postural balance in elderly women receiving estrogens. Am J Obstet Gynecol (1997) 0.96
Diet and hip fracture risk: a case-control study. Study Group of the Multiple Risk Survey on Swedish Women for Eating Assessment. Int J Epidemiol (1995) 0.93
Heterogeneity of age-related fractures: implications for epidemiology. Bone Miner (1987) 0.90
Effects of hormonal replacement therapy on the postural balance among postmenopausal women. Obstet Gynecol (1996) 0.85
Fracture protection provided by long-term estrogen treatment. Osteoporos Int (1995) 0.83
Role of oestrogen in the development of osteoporosis. Calcif Tissue Int (1991) 0.82
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int (2008) 8.75
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am (2001) 7.67
The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health (1992) 6.97
World-wide projections for hip fracture. Osteoporos Int (1997) 6.83
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med (1994) 5.98
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
The framing effect of relative and absolute risk. J Gen Intern Med (1993) 4.87
Prognosis of cancers associated with venous thromboembolism. N Engl J Med (2000) 4.51
Ethics of a prostate cancer screening trial. Lancet (1994) 4.21
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years. J Bone Joint Surg Br (2002) 3.40
Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int (2001) 3.23
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly. Am J Epidemiol (1996) 3.16
Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Exercise during growth and bone mineral density and fractures in old age. Lancet (2000) 3.06
Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int (2000) 2.99
An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int (2001) 2.94
Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum (1997) 2.93
The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int (2001) 2.81
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut (2008) 2.79
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
The components of excess mortality after hip fracture. Bone (2003) 2.63
Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int (2000) 2.52
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
Projecting the need for hip replacement over the next three decades: influence of changing demography and threshold for surgery. Ann Rheum Dis (1999) 2.36
Epidemiology of renal stones in a middle-aged male population. Acta Med Scand (1975) 2.35
Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol (1989) 2.35
Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med (1988) 2.33
Hip fracture incidence and mortality in New England. Epidemiology (1991) 2.32
Smoking and estrogen-related disease. Am J Epidemiol (1984) 2.31
SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab (2006) 2.25
Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect (1998) 2.22
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18
The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther (2015) 2.16
Jewish religion and risk of breast cancer. Lancet (1996) 2.14
Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut (1998) 2.14
A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med (1990) 2.13
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet (1999) 2.12
Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int (2004) 2.11
Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia (1997) 2.11
Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med (1995) 2.08
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Conservative treatment of acute low-back pain. A prospective randomized trial: McKenzie method of treatment versus patient education in "mini back school". Spine (Phila Pa 1976) (1990) 2.01
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Electric blanket or mattress cover use and breast cancer incidence in women 50-79 years of age. Epidemiology (2001) 1.96
The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96
Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost (2009) 1.95
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone (2000) 1.89
Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Public Health (1990) 1.88
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ (2002) 1.85
Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens (1995) 1.85
Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol (1997) 1.83
Treatment and survival among elderly Americans with hip fractures: a population-based study. Am J Public Health (1994) 1.83
Effect of intravenous streptokinase on early mortality in patients with suspected acute myocardial infarction. A meta-analysis by anatomic location of infarction . Ann Intern Med (1990) 1.82
The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int (1992) 1.81
Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76
Are the findings in the Swedish National Total Hip Arthroplasty Register valid? A comparison between the Swedish National Total Hip Arthroplasty Register, the National Discharge Register, and the National Death Register. J Arthroplasty (2000) 1.75
The risk and burden of vertebral fractures in Sweden. Osteoporos Int (2003) 1.74
Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int (2003) 1.74
Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med (2000) 1.73
Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke (2001) 1.73
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int (2002) 1.70
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod (2006) 1.69
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas (1995) 1.67
Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med (1992) 1.67
Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol (1998) 1.66
Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol (1999) 1.65
Surgical versus non-surgical treatment of ligamentous injuries following dislocation of the elbow joint. A prospective randomized study. J Bone Joint Surg Am (1987) 1.63
Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol (2004) 1.62
Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol (1989) 1.62
Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control (2000) 1.61
Bone metabolism in endurance trained athletes: a comparison to population-based controls based on DXA, SXA, quantitative ultrasound, and biochemical markers. Calcif Tissue Int (1997) 1.61
Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. Osteoporos Int (1994) 1.60
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med (2001) 1.59